Metal-Organic Frameworks (MOFs)-Based Nanomaterials as Highly Efficient Drug/Gene Agents

A special issue of Inorganics (ISSN 2304-6740). This special issue belongs to the section "Bioinorganic Chemistry".

Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 1296

Special Issue Editors

E-Mail Website
Guest Editor
1. School of Engineering, Macquarie University, Sydney, NSW 2109, Australia
2. Department of Physics, Sharif University of Technology, Tehran P.O. Box 11155-9161, Iran
Interests: bioinorganic chemistry; gene delivery; metallocenter assembly; drug delivery; structure/function relationships in metal coordination chemistry; biomedical engineering; biomaterials; inorganic chemisry; metal-organic frameworks (MOFs); CRISPR/Cas9; CRISPR technology; porous nanomaterials; nanotechnology; biotechnology
Special Issues, Collections and Topics in MDPI journals

grade E-Mail Website
Guest Editor
Departamento de Química Orgánica, Universidad de Córdoba, Campus de Rabanales, Edificio Marie Curie (C-3), Ctra Nnal IV-A, Km 396, Córdoba, Spain
Interests: green chemistry; biomass valorization; heterogeneous catalysis; nanomaterial design
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Several attempts have been made in the design, synthesis, characterization and optimization of different types of nanomaterials and non-viral drug/gene delivery vectors. In this regard, porous nanomaterials including metal–organic frameworks (MOFs), covalent–organic frameworks (COFs), zeolites and organic porous nanomaterials have been studied. Some critical factors for biomedical optimization include zeta potential, hydrodynamic particle size, molecular weight, cytotoxicity, cytocompatibility, bioavailability and other physicochemical/biological properties. MOF-based nanomaterials show superior behaviour compared to other types of porous nanomaterials; therefore, the importance and popularity of research is increasing all the time. MOFs are useful due to their high potential in optimizing physicochemical performance as well as biological performance. Additionally, their cytotoxicity on different cells lines depends on different mechanisms; therefore, investigating their potential as promising nanocarriers for efficient drug/gene delivery applications is of great importance.

In this Special Issue, we wish to cover the most recent advances in all these aspects of MOF-based nanomaterials biochemistry for targeted and efficient drug/gene delivery applications, by hosting a mix of original research articles and short critical reviews.

Dr. Navid Rabiee
Prof. Dr. Rafael Luque
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Inorganics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • MOFs biochemistry
  • drug/gene delivery
  • targeted delivery
  • CRISPR/Cas9
  • CRISPR technology
  • gene editing
  • chemotherapy
  • photothermal therapy
  • cancer therapy
  • non-viral drug/gene delivery vectors
  • green synthesis

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop